Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease.
Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson's disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5841660?pdf=render |
id |
doaj-880fb56cc2ff42b4bad956b902f0d7d5 |
---|---|
record_format |
Article |
spelling |
doaj-880fb56cc2ff42b4bad956b902f0d7d52020-11-24T21:40:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01133e019249710.1371/journal.pone.0192497Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease.Lara MarroneChristine BusDavid SchöndorfJulia Catherine FitzgeraldManuela KüblerBenjamin SchmidPeter ReinhardtLydia ReinhardtMichela DeleidiTanya LevinAndrea MeixnerBarbara KlinkMichael GlatzaChristian Johannes GloecknerThomas GasserJared SterneckertInduced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson's disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for the most common forms of PD are critically lacking. Here, we report the generation of an iPSC-based model of idiopathic PD (iPD) with or without RS1491923, which is a common risk variant in the LRRK2 locus. Consistent with GWA studies, we found large variability in our datasets. However, iPSC-derived neurons carrying the risk allele emerged for displaying subtle disturbances of cellular degradative systems, in line with familial PD models. We also observed that treatment with the LRRK2 inhibitor CZC-25146 slightly reduced a marker of aSYN pathology in all iPD lines. Future iPSC-based studies may need to be structured similarly to large GWA studies in order to obtain relevant statistical power. However, results from this pilot study suggest that iPSC-based modeling represents an attractive way to investigate idiopathic diseases.http://europepmc.org/articles/PMC5841660?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lara Marrone Christine Bus David Schöndorf Julia Catherine Fitzgerald Manuela Kübler Benjamin Schmid Peter Reinhardt Lydia Reinhardt Michela Deleidi Tanya Levin Andrea Meixner Barbara Klink Michael Glatza Christian Johannes Gloeckner Thomas Gasser Jared Sterneckert |
spellingShingle |
Lara Marrone Christine Bus David Schöndorf Julia Catherine Fitzgerald Manuela Kübler Benjamin Schmid Peter Reinhardt Lydia Reinhardt Michela Deleidi Tanya Levin Andrea Meixner Barbara Klink Michael Glatza Christian Johannes Gloeckner Thomas Gasser Jared Sterneckert Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. PLoS ONE |
author_facet |
Lara Marrone Christine Bus David Schöndorf Julia Catherine Fitzgerald Manuela Kübler Benjamin Schmid Peter Reinhardt Lydia Reinhardt Michela Deleidi Tanya Levin Andrea Meixner Barbara Klink Michael Glatza Christian Johannes Gloeckner Thomas Gasser Jared Sterneckert |
author_sort |
Lara Marrone |
title |
Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. |
title_short |
Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. |
title_full |
Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. |
title_fullStr |
Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. |
title_full_unstemmed |
Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. |
title_sort |
generation of ipscs carrying a common lrrk2 risk allele for in vitro modeling of idiopathic parkinson's disease. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson's disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for the most common forms of PD are critically lacking. Here, we report the generation of an iPSC-based model of idiopathic PD (iPD) with or without RS1491923, which is a common risk variant in the LRRK2 locus. Consistent with GWA studies, we found large variability in our datasets. However, iPSC-derived neurons carrying the risk allele emerged for displaying subtle disturbances of cellular degradative systems, in line with familial PD models. We also observed that treatment with the LRRK2 inhibitor CZC-25146 slightly reduced a marker of aSYN pathology in all iPD lines. Future iPSC-based studies may need to be structured similarly to large GWA studies in order to obtain relevant statistical power. However, results from this pilot study suggest that iPSC-based modeling represents an attractive way to investigate idiopathic diseases. |
url |
http://europepmc.org/articles/PMC5841660?pdf=render |
work_keys_str_mv |
AT laramarrone generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT christinebus generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT davidschondorf generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT juliacatherinefitzgerald generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT manuelakubler generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT benjaminschmid generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT peterreinhardt generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT lydiareinhardt generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT micheladeleidi generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT tanyalevin generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT andreameixner generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT barbaraklink generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT michaelglatza generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT christianjohannesgloeckner generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT thomasgasser generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT jaredsterneckert generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease |
_version_ |
1725923983754264576 |